Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Refractive Index Method Development – V 2.0

Posted on By

Analytical Method Development: Refractive Index Method Development – V 2.0

SOP for Development of Refractive Index Method in Analytical Method Development Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/065/2025
Supersedes SOP/AMD/065/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the methodology for developing and validating refractive index (RI)-based analytical methods to qualitatively identify or quantitatively determine the concentration or purity of pharmaceutical compounds, primarily for substances

that are colorless or dissolved in aqueous or organic solvents.

2. Scope

This procedure applies to the Analytical Method Development (AMD) department and covers RI-based techniques for raw material qualification, purity profiling, and concentration measurement in liquid formulations, extracts, and solvents used in pharmaceutical analysis.

3. Responsibilities

  • Analytical Chemist: Conducts method development and validation trials using RI instrumentation, records observations, and ensures instrument calibration.
  • Reviewer: Reviews data for consistency, verifies calibration records, and ensures traceability.
  • QA Officer: Ensures regulatory compliance, proper documentation, and audit readiness.
  • Head – AMD: Approves the developed and validated method for routine or regulatory application.

4. Accountability

The Head of Analytical Method Development is accountable for the approval, implementation, and maintenance of accurate RI methods in line with regulatory and pharmacopoeial standards.

See also  Analytical Method Development: pH Method Development for Formulations - V 2.0

5. Procedure

5.1 Principle of Refractive Index

  1. Refractive index (n) is the ratio of the speed of light in vacuum to its speed in a given substance.
  2. RI varies with concentration, temperature, and wavelength of light; RI measurements can help determine identity or concentration of solutes in solvents.
  3. Measurement is performed using an Abbe refractometer or digital refractometer at standard temperature (usually 20°C or 25°C).

5.2 Instrumentation and Calibration

  1. Use calibrated digital or analog refractometers suitable for pharmaceutical applications.
  2. Calibrate instrument using certified reference standard such as:
    • Distilled water (RI = 1.3330 at 20°C)
    • Sodium chloride or sucrose solution (known RI)
  3. Clean prism surfaces thoroughly before and after each use.
  4. Document instrument ID and calibration in Annexure-1: Instrument Calibration Log.

5.3 Sample Preparation

  1. Use transparent, colorless, particle-free liquids for accurate RI reading.
  2. Filter solutions using 0.45 µm membrane if particulate matter is present.
  3. Maintain temperature control during sample preparation and analysis.
  4. Document sample batch, concentration, solvent system, and preparation method in Annexure-2: Sample Preparation Log.

5.4 RI Measurement Procedure

  1. Switch on the refractometer and allow for stabilization as per manufacturer’s instructions.
  2. Verify instrument calibration using reference standard.
  3. Place 2–3 drops of test sample onto the prism using a clean glass rod or dropper.
  4. Close the prism lid gently and allow temperature equilibrium.
  5. Record RI value displayed by the instrument. For analog, read from scale or via compensation wheel.
  6. Clean the prism using distilled water followed by ethanol and wipe with lint-free tissue.
  7. Perform triplicate measurements for each sample and calculate average.
  8. Document all readings in Annexure-3: RI Observation Log.
See also  Analytical Method Development: Moisture Analysis Method for Hygroscopic APIs - V 2.0

5.5 Calculation

Average RI = (RI₁ + RI₂ + RI₃) / 3

Where RI₁, RI₂, and RI₃ are individual replicate readings.

5.6 Method Optimization

  1. Evaluate:
    • Effect of sample temperature (e.g., 20°C vs 25°C)
    • Concentration-dependence for quantitative interpretation
    • Matrix interference (e.g., solvent effect)
  2. Develop calibration curve for quantitative analysis using standard solutions (e.g., sucrose, API in solvent).
  3. Determine linearity range and optimum concentration window.
  4. Document in Annexure-4: Method Optimization Report.

5.7 Method Validation

  1. Specificity: Confirm that the sample matrix does not interfere with RI reading.
  2. Linearity: Plot RI vs. known concentrations. Acceptable R² ≥ 0.999.
  3. Accuracy: Perform recovery study with known standard solution and compare theoretical RI.
  4. Precision: Evaluate repeatability across 6 replicates (RSD ≤ 1.0%).
  5. Robustness: Check reproducibility under ±2°C temperature variation.
  6. Document validation results in Annexure-5: Validation Summary Report.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • RI: Refractive Index
  • RSD: Relative Standard Deviation
  • AMD: Analytical Method Development

7. Documents

  1. Instrument Calibration Log – Annexure-1
  2. Sample Preparation Log – Annexure-2
  3. RI Observation Log – Annexure-3
  4. Method Optimization Report – Annexure-4
  5. Validation Summary Report – Annexure-5
See also  Analytical Method Development: Total Ash and Acid Insoluble Ash Method Development - V 2.0

8. References

  • USP General Chapter <831> – Refractive Index
  • EP 2.2.6 – Refractive Index
  • ICH Q2(R1) – Validation of Analytical Procedures
  • Pharmacopoeia of India – Refractive Index Sections

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Instrument Calibration Log

Instrument ID Standard Used Observed RI Acceptance Range Status Analyst
RI-102 Distilled Water 1.3331 1.3329–1.3331 Pass Sunita Reddy

Annexure-2: Sample Preparation Log

Sample Code Solvent Concentration Temperature Prepared By
API-SOL-A Water 1.0% w/v 25°C Rajesh Kumar

Annexure-3: RI Observation Log

Trial RI Value Average RI Status
1 1.3625 1.3624 Pass
2 1.3623
3 1.3624

Annexure-4: Method Optimization Report

Parameter Variation Observation Conclusion
Temperature 20°C vs 25°C RI increased slightly Use 25°C consistently

Annexure-5: Validation Summary Report

Parameter Criteria Result Status
Accuracy ±0.001 RI units ±0.0004 Pass
Precision RSD ≤ 1.0% 0.38% Pass
Linearity R² ≥ 0.999 0.9992 Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded method validation and included digital RI instrumentation steps Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Biosimilars: SOP for Scale-Up from Shake Flask to Spinner Flask – V 2.0
Next Post: BA-BE Studies: SOP for Ensuring Adequate Staffing in Clinical Units – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version